Hims Shares Drop After Quarterly Sales Miss Wall Street’s Estimates

Hims & Hers Health Inc.’s shares dropped in early trading Tuesday after the telehealth company missed second-quarter revenue estimates.

The San Francisco-based company recorded sales of $545 million for the three months ended June 30, according to a statement, below Wall Street’s average estimate of $552 million. Hims reaffirmed its full-year revenue guidance of $2.3 billion to $2.4 billion.